To explore how the loss of Phex function contributes to the pathogenesis of osteomalacia, we examined the abnormalities of mineralization, Phex, and bone matrix protein expression occurring in Hyp mice in vivo and in ex vivo bone marrow cell cultures. The results in vivo show that mineralization was decreased significantly in Hyp mouse bone. Phex protein was identifiable in osteoblasts and osteocytes in wild-type mice, but not in Hyp mice. In Hyp mice, osteocalcin, bone sialoprotein, and vitronectin expression were down-regulated, whereas biglycan and fibrillin-1 expression were up-regulated in osteocytes and bone matrix relative to those in their wild-type counterparts. Parallel studies ex vivo demonstrated that cells derived from 18-day Hyp mouse bone marrow cell cultures had a 3Ј-Phex deletion, no Phex protein expression, decreased alkaline phosphatase activity, collagen deposition, and calcium accumulation, and reduced osteocalcin, bone sialoprotein, and vitronectin at both the protein and messenger RNA levels. Furthermore conditioned medium from Hyp mouse bone marrow cultures could induce analogous defects in bone marrow cell cultures of wild-type cells. These novel findings indicate that there is an intrinsic osteogenic cell differentiation defect in addition to the known hypomineralization of bone in Hyp mice, which may be inducible by an autocrine/paracrine secreted factor. These results suggest that alterations in the Phex gene may control bone matrix mineralization indirectly by regulating the synthesis and deposition of bone matrix proteins. (Endocrinology 142: 926 -939, 2001) 
X
-LINKED HYPOPHOSPHATEMIC rickets (Hyp) is the most common inherited form of rickets in humans. Patients typically present with lower extremity deformities, rickets, short stature, bone pain, dental abscesses, and osteomalacia. The hallmark of the disorder is renal phosphate wasting with resulting hypophosphatemia (1) .
Many insights into the pathogenesis of Hyp have been derived from studies of a murine homolog of the human disease observed in Hyp mice. Linkage studies in the mouse have mapped the Hyp mutation to a region of the mouse X-chromosome syntenic to the human Hyp locus. The Hyp mouse arose naturally as a spontaneous mutation and has since been bred on the C57BL/6J background. Like their human counterparts, this murine model has renal phosphate wasting, impaired mineralization, and growth retardation. The renal defect in phosphate reabsorption in Hyp mice is believed to reside at the level of the brush-border membrane of the proximal tubule (2) . To evaluate whether the phosphate wasting resulted from a primary renal defect or from elaboration of a humoral factor that alters phosphate uptake in the renal proximal tubule, Meyer et al. (3) initially performed parabiosis experiments and suggested the presence of a circulatory phosphaturic substance that was subsequently termed phosphatonin (4). Nesbitt et al. (5) performed renal cross-transplantation between Hyp and normal mice. They found that when normal kidneys were transplanted into nephrectomized Hyp mice, the kidneys wasted phosphorus. When Hyp kidneys were transplanted into nephrectomized normal mice, the kidneys retained phosphorus normally. Thus, the defect in the Hyp mouse is neither corrected nor transferred by renal cross-transplantation, indicating that the phosphate transport defect in the Hyp mouse is not due to an intrinsic renal abnormality.
In view of the prominence of the skeletal phenotype in this disorder, considerable attention in recent years has been directed at the skeletal osteoblast. An intrinsic osteoblast defect was proposed by Ecarot et al. (6 -8) , who performed experiments transplanting periostea and osteoblasts into the gluteal muscles of normal and Hyp mice. When normal cells were transplanted into Hyp mice, mineralization was impaired. However, when Hyp cells were transplanted into normal mice, reduction, but not normalization, of mineralization was observed. These studies supported the hypothesis that there is a primary osteoblast defect in the Hyp mouse, but did not definitively exclude the possibility that a putative circulating factor in the Hyp mouse could lead to a prolonged defect in the osteoblast.
More recently, a positional cloning approach was used to identify PHEX (phosphate-regulating gene with homology to endopeptidases on the X-chromosome) as the candidate gene for Hyp (9) . Human and mouse PHEX/Phex comple-mentary DNAs have now been cloned and sequenced (10 -14) . Amino acid sequence comparisons have demonstrated structural homologies between PHEX/Phex. Whereas several investigations have examined PHEX/Phex expression at the tissue level using a variety of techniques (10 -12, 15-17) and have shown that PHEX/Phex messenger RNA (mRNA) expression is predominantly in bone and teeth, the mechanism by which loss of PHEX/Phex function leads to disease is not immediately apparent.
The organic constituents of bone form a well organized extracellular matrix whose main component is type I collagen, but which also contains, on a molar basis, a roughly equal proportion of noncollagenous proteins (NCPs). It is thought that these proteins play critical roles in regulating mineralization and in facilitating the attachment of osteoblasts and osteoclasts to the bone matrix. Accordingly, investigation of the changes in NCP content and distribution may yield valuable insight into the pathogenesis of Hyp osteomalacia and bone mineralization in general. However, relatively few data are available regarding the abnormalities of NCPs in hypophosphatemia, and these stem largely from analysis of Hyp serum and Hyp-derived osteoblast cultures. To date, no abnormalities of NCP expression and distribution have been reported in intact Hyp bone.
In the present study to explore how the loss of Phex function contributes to the pathogenesis of osteomalacia, we have addressed several questions. 1) Which cells in intact normal bone synthesize and secrete Phex protein? 2) What is the relationship between the Phex abnormality and osteomalacia in Hyp mice? 3) Are there alterations in the expression and secretion of bone matrix proteins in situ in Hyp mice? 4) Besides the mineralization defect, are there osteogenic cell differentiation defects? To answer these questions, we have examined the abnormalities of mineralization, Phex and bone matrix protein expression, and extracellular localization occurring in Hyp mice in vivo and investigated whether there were any osteogenic cell differentiation and mineralization defects by using ex vivo bone marrow cell cultures.
Materials and Methods Antibodies
Rabbit antiserum against a synthetic peptide, ESEEKPKEK, corresponding to residues 606 -614 of the carboxyl-terminal amino acid sequence of PHEX; goat antimouse osteocalcin (Biomedical Technologies, Stoughton, MA); affinity-purified goat antihuman type I collagen antibody (Southern Biotechnology Associates, Birmingham, AL); rabbit antimouse vitronectin (courtesy of Dr. D. Seiffert, Scripps Research Institute, La Jolla, CA); rabbit antimouse fibrillin-1 antibodies (courtesy of Dr. L. Sakai, University of Washington, Seattle, WA); rabbit antihuman bone sialoprotein (LF-6) (18); and rabbit antimurine biglycan (LF-106) (19) antibodies (courtesy of Dr. L. W. Fisher, NIDCR, NIH, Bethesda, MD) were employed.
Animals
All mice used were of the C57BL/6J strain. Inbred Hyp mice were initially obtained from The Jackson Laboratory (Bar Harbor, ME). Normal and Hyp mice were bred and maintained on Purina chow (Ralston Purina Co. of Canada Ltd., Montréal, Canada) containing 0.5% calcium and 0.74% phosphorus. Normal males (ϩ/Y) and hemizygous Hyp males (Hyp/Y), aged 45-50 days, were used in these experiments.
Histology
Six 40-to 45-day-old age-matched, male, wild-type and Hyp mice were killed by cervical dislocation. The distal ends of femurs were removed, dissected free of soft tissue, and fixed in PLP fixative (2% paraformaldehyde containing 0.075 m lysine and 0.01 m sodium periodate solution) for 24 h at 5 C. The left distal femurs were then decalcified in EDTA-glycerol solution (14.5 g EDTA, 15 ml of glycerol, and 85 ml distilled water with solid sodium hydroxide added until a final pH of 7.3 was reached) for 5-7 days at 5 C. Tissues were dehydrated in graded alcohols and embedded in low melting point paraffin, after which 5-m sections were cut on a rotary microtome. The sections were immunostained as described below. Undecalcified right distal ends of femurs were embedded in LR White acrylic resin (London Resin Co. Ltd., London, UK). One-micron sections were cut on an ultramicrotome. These sections were stained for mineral with the von Kossa staining procedure and counterstained with toluidine blue.
Bone marrow cell cultures
Tibiae and femurs of 40-to 45-day-old age-matched, male, wild-type and Hyp mice were removed under aseptic conditions, and bone marrow cells (BMC) were flushed out with DMEM containing 15% FCS, 50 g/ml ascorbic acid, 10 mm ␤-glycerophosphate, and 10 Ϫ8 m dexamethasone. Cells were dispersed by repeated pipetting, and a single cell suspension was achieved by forcefully expelling the cells through a 22-gauge syringe needle. No selection for cells of the osteoblast lineage was made. Total bone marrow cells (10 6 ) were cultured in 36-cm 2 petri dishes in 5 ml of the above-mentioned medium. Such cultures have previously been shown to contain osteogenic cell precursors, which in culture can produce mineralized bone nodules (20, 21) . The medium was changed every 4 days, and cultures were maintained for 18 days. Conditioned medium was harvested every 4 days from normal and Hyp mouse BMC cultures. At the end of the culture period cells were washed with PBS, fixed with PLP fixative, and stained cytochemically or immunocytochemically. Total RNA was extracted for RT-PCR, and proteins were extracted for Western blotting, as described below.
Cytochemical staining
Alkaline phosphatase (ALP) cytochemistry. Cells were incubated for 15 min at room temperature in 100 mm Tris-maleate buffer containing naphthol AS-MX phosphate (0.2 mg/ml; Sigma) dissolved in ethylene glycol monomethyl ether (Sigma) as a substrate and Fast Red TR (0.4 mg/ml; Sigma) as a stain for the reaction product. After washing with distilled water and air-drying, ALP-positive colony areas were measured by image analysis as described below.
Alizarin Red S staining for calcium. Cells were exposed to a solution of Alizarin Red S, pH 6.2 (1 mg/mg), for 30 min at room temperature, after which the colonies were gently washed under running water and left to dry. Images of stained petri dishes were photographed (see below). The colonies were destained for further analysis (collagen staining) by briefly washing in 5% perchloric acid.
Picrosirius red staining for collagen. Cells were exposed to 1% sirius red in saturated picric acid for 30 min. Stained cell layers were washed in water thoroughly to remove any nonspecific staining and dried before images were taken.
Methylene blue staining for total colony assessment. Cells were first washed in borate buffer (10 mm; pH 8.8) before staining with 1% methylene blue (wt/vol) in borate buffer for 30 min at room temperature. Cells were then washed three times in borate buffer alone and left to dry. Images of stained petri dishes were taken.
Immunocytochemistry and immunohistochemistry
Cultured cells in petri dishes or paraffin sections of decalcified bone were stained immunocyto/histochemically for Phex and bone matrix proteins using the avidin-biotin-peroxidase complex (ABC) technique (22) . The cultured cells or dewaxed sections of bone were first treated with 1% bovine testicular hyaluronidase (Sigma) for 30 min at 37 C to increase antibody penetration and access to epitopes. Primary antibody was applied to tissues or cells overnight at room temperature. As a negative control, the preimmune serum or TBS (50 mm Tris-HCl, 150 mm NaCl, and 0.01% Tween-20, pH 7.6) was substituted for the primary antibody. After washing with high salt buffer (50 mm Tris-HCl, 2.5% NaCl, and 0.05% Tween-20, pH 7.6) for 10 min at room temperature followed by two 10-min washes with TBS, the cells were incubated with secondary antibody [biotinylated rabbit antigoat IgG, biotinylated goat antirabbit IgG, biotinylated goat antimouse IgG, Fab special, (Sigma)]. Cells or sections were then washed as before and incubated with the Vectastain ABC-AP kit or the Vectastain Elite ABC kit (Vector Laboratories, Inc. Ontario, Canada) for 45 min. After washing as before, red pigmentation to demarcate regions of immunostaining was produced by a 10-to 15-min treatment with Fast Red TR/Naphthol AS-MX phosphate (Sigma; containing 1 mm levamisole as endogenous ALP inhibitor), or gray pigmentation was likewise produced using a Vector SG kit (Vector Laboratories, Inc.). After washing with distilled water, the sections were counterstained with methyl green and mounted with Kaiser's glycerol jelly.
Computer-assisted image analysis
After immunostaining of three each of age-matched, male wild-type and Hyp mice, images of primary spongiosa and cortical bone from a single section from one femur were digitally recorded using a rectangular template and three different fields. In the primary spongiosa, each image was photographed from the edge of the metaphyseal border of the growth plate (i.e. at the level of the zone of vascular invasion). In cortical bone, images were taken from the diaphyseal bone close to the metaphysis. All digital images were captured at a magnification of ϫ200, producing a field area of 0.4 mm 2 . For the cultured cells, dish images were photographed with transmitted light over a light box. All images were taken with a Sony digital camera, and processed using Northern Eclipse image analysis software, version 5.0 (Empix Imaging, Inc., Mississauga, Canada). For determining the area and density of the mineralized matrix and bone matrix proteins in stained bone sections and positive colonies in cultured cells, thresholds were set using green and red channels. The thresholds were determined interactively and empirically on the basis of three different images. Subsequently, this set threshold was used to automatically analyze all recorded images of all sections that were stained in the same staining session under exactly the same conditions. The ratio of the area of the mineralized matrix and the area of cytochemical or immunohistochemical stained regions was calculated automatically by the software in each microscopic field. Pixel counts (summary total gray) of immunoreaction products (i.e. bone matrix proteins) were also calculated from thresholding of each microscopic field (0.4 mm 2 ); these data reflect the relative amount of bone matrix proteins, as measured by immunostaining intensity. The software therefore determines summary total gray as the integrated immunostaining intensity over a given tissue area.
Western blot analysis
Proteins were extracted from 18-day cultures and quantitated by the protein assay kit (Bio-Rad Laboratories, Inc., Mississauga, Canada). Protein samples (100 g) were fractionated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane. Immunoblotting was carried out using the antibodies described above. Bands were visualized using the ECL chemiluminescence detection method (Amersham Pharmacia Biotech, Aylesbury, UK). Western products were quantified by image analysis using NIH 1.61 image software.
RT-PCR
Total RNA for RT-PCR was extracted from 18-day cultures by a single step method using TRIzol reagent, reverse transcribed, and amplified by PCR using QIAGEN One-Step TR-PCR kit (QIAGEN, Mississauga, Canada) according to the manufacturer's instructions. The primer sets employed are depicted in Table 1 .
Statistical analysis
Data are presented as the mean Ϯ se. Statistical comparisons were made using Student's t test, with P Ͻ 0.05 being considered significant.
Results

Histological and immunohistochemical localization of Phex and bone matrix proteins in normal and Hyp bone
To investigate a possible relationship between expression levels of Phex protein, bone matrix proteins, and mineral deposition, von Kossa staining and immunohistochemistry for Phex protein and bone matrix proteins were performed on sections of femurs from wild-type and Hyp mice, and the resulting positive reaction products were quantified by image analysis. Alterations in mineralization and localization of Phex protein and bone matrix proteins in Hyp mice were observed as follow. 
Osteomalacia in Hyp mice as demonstrated by von Kossa staining
Mineralized bone matrix was demonstrated in trabecular and cortical bone in wild-type mice (Figs. 1, A and C, respectively). In Hyp mice, a disproportionately large amount of unmineralized bone matrix was seen in trabecular and cortical bone (Fig. 1, B and D, respectively, asterisks) . Typical, hypomineralized periosteocytic lesions were also observed in both trabecular and cortical bone of Hyp mice (Fig. 1, B and D, respectively, arrow, inset). Quantitative data derived from image analysis showed that total mineral per unit area was decreased by 82.6% in the primary spongiosa and by 50.7% in cortical bone when comparing Hyp to wild-type mice.
Expression of Phex protein in osteoblasts and osteocytes in wild-type mice, but not in Hyp mice
The localization of Phex protein was performed using a rabbit antiserum against a synthetic peptide representing a fragment of the carboxyl-terminal amino acid sequence of Phex. Phex protein was identified in selected osteoblasts and in most osteocytes in wild-type mice (Fig. 1 , E and G), but not in Hyp mice (Fig. 1, F and H) . Immunohistochemical staining of Phex protein was also stronger in osteocytes than in osteoblasts and localized predominantly to the plasma membrane (Fig. 1E, inset) .
Immunohistochemistry for type I collagen in primary spongiosa and cortical bone
Immunolocalization of type I collagen in trabecular (Fig.  2, A and B) and cortical (Fig. 2 , D and E) bone was similar between wild-type and Hyp mice. Type I collagen was detected by intense staining of bone matrix and by faint staining of osteoblasts in both wild-type (Fig. 2, A and D) and Hyp (Fig. 2, B and E) mice. No obvious differences were apparent in the distribution pattern of type I collagen in cortical bone between wild-type ( Fig. 2D) and Hyp (Fig. 2E) mice. Likewise, a similar abundance of immunodetectable type I collagen relative to total tissue area was seen in the primary spongiosa between wild-type and Hyp mice. When observations were made, relative to trabecular area, rather than relative to the entire primary spongiosa, however, there was less immunostaining in Hyp mice than in wild-type mice (confirmed by quantitation data below). This reduction in the ratio of type I collagen in the trabecular area in Hyp vs. wild-type mice was attributable primarily to wider trabeculae and more trabecular area in the Hyp mice than in wildtype mice. More remnant cartilage matrix was evident within the larger trabeculae in Hyp mice compared with wild-type mice, as evidenced by type II collagen immunostaining (23) , and in both Hyp mice and wild-type mice, little or no immunostaining was observed for type I collagen in remnant cartilage matrix within trabecular and cortical bone.
Quantitative data from image analysis and thresholding for the immunopositive reaction product for type I collagen showed that it was at a similar abundance in wild-type and Hyp mice. Although the positive percent area and abundance (summary total gray) was somewhat increased in the primary spongiosa relative to the total tissue area for this protein, the positive percentage relative to trabecular area was decreased by 27.5% in Hyp mice confirming the qualitative analysis in Fig. 3 . No difference was seen in cortical bone (Fig. 4) .
Immunohistochemistry for osteocalcin, bone sialoprotein, and vitronectin in primary spongiosa and cortical bone: down-regulated in Hyp mice
Osteocalcin was observed by immunostaining in bone matrix, osteocytes, and osteoblasts in wild-type mice (Fig. 5, A  and C) . Although a similar staining pattern was observed for osteocalcin in Hyp mice (Fig. 5, B and D) , there were some regions of cortical bone matrix that were strikingly devoid of immunodetectable osteocalcin in the Hyp mice (Fig. 5D) .
In wild-type mice, bone sialoprotein was observed in osteoid and osteocytes at high levels, and in bone matrix and osteoblasts at somewhat lower levels (Fig. 5, E and G) . Its localization in both osteocytes and most regions of bone matrix was reduced in Hyp mice (Fig. 5, F and H) .
Vitronectin was found in bone matrix and some osteocytes at high levels, whereas in other osteocytes immunostaining was weak in wild-type mice (Fig. 5, I and K). Immunostaining for vitronectin decreased in both osteocytes and most regions of bone matrix in Hyp mice (Fig. 5, J and L) . In wild-type mice, little or no staining for osteocalcin, bone sialoprotein, or vitronectin was detectable in remnant cartilage matrix within trabecular and cortical bone.
Quantitative data from image analysis for the immunoreactive osteocalcin, bone sialoprotein, and vitronectin showed that although their percent positive area and abundance were not altered significantly in primary spongiosa relative to total tissue area, their percent positive area relative to trabecular area decreased substantially by 50.4%, 34.6%, and 54.2% in Hyp mice, respectively (Fig. 3) . In cortical bone their percent positive area and abundance (summary total gray) were also decreased significantly in Hyp mice (Fig. 4) . Less intense staining of bone matrix proteins could reflect decreased synthesis, secretion, and/or retention in the bone matrix.
Immunohistochemistry for biglycan and fibrillin-1 in primary spongiosa and cortical bone: up-regulated in Hyp mice
In wild-type mice, biglycan was detected by immunohistochemistry predominantly in osteoid and some osteocytes and to a lesser extent in some osteoblasts and subperiosteal cells (Fig. 6, A and C) . Weak staining was observed in bone matrix and remnant cartilage matrix in primary spongiosa and cortical bone in wild-type mice (Fig. 6, A and C) . In Hyp mice, biglycan staining was increased in osteocytes, most regions of bone matrix, and remnants of cartilage matrix (Fig.  6, B and D) .
Fibrillin-1 staining in wild-type mice showed positive immunoreactivity in osteoblasts, some osteocytes, and some regions of bone matrix and remnant cartilage matrix in the primary spongiosa and cortical bone (Fig. 6, E and G) . Its localization in osteocytes, most regions of bone matrix, and remnant cartilage matrix in primary spongiosa and cortical bone was increased in Hyp mice (Fig. 6, F and H) . Quantitative data from image analysis of the immunoreactivity for biglycan and fibrillin-1 showed that their percent positive area and abundance were greatly increased in cortical and trabecular bone in Hyp mice (Figs. 3 and 4) .
Osteogenic cell differentiation and mineralization and protein and gene expression of Phex protein and bone matrix proteins in ex vivo BMC cultures
To explore whether changes in bone result from intrinsic osteogenic abnormalities and/or an altered extracellular environment, we employed ex vivo primary BMC cultures. Such cultures have previously been shown to contain osteogenic cell precursors, which in culture can produce mineralized bone nodules (20, 21) .
Osteogenic cell differentiation and mineralization defects in Hyp mice
We first assessed osteogenic cell growth, differentiation, and mineralization in wild-type and Hyp mice by sequential cytochemical staining of 18-day cultures for total colonies and ALP, calcium, and collagen positive colonies. The quantitation of total colony area and of ALP-, collagen-, and calcium-positive colonies was determined by image analysis. Results showed that total colony area was unchanged; however, areas of ALP-, collagen-, and calcium-positive colonies were decreased significantly in Hyp mouse cultures compared with the wild-type mouse cultures (Fig. 7A) . When the positive percentages of ALP-, collagen-, and calcium-positive colonies relative to total colonies were calculated, all were lower in the Hyp mouse cultures than in wild-type mouse cultures (Fig. 7B) . When the percentages of ALP-, collagen-, and calcium-positive colonies in Hyp mice relative to wildtype mice were calculated, ALP-and collagen-positive colony areas were decreased by 25.1% and 45.8%, respectively. The mineralized area was decreased by 58.4% (Fig. 7C) . Those findings suggest that although cell growth was not impaired in the cultures, osteogenic cell differentiation and mineralization were retarded.
Absence of Phex protein expression in cells from primary Hyp mouse BMC cultures
To confirm the presence of a Phex mutation in cells from Hyp mouse BMC cultures, we examined Phex mRNA expression and Phex protein expression in these cells. RT-PCR results demonstrated that cells from 18-day wild-type mouse BMC cultures expressed both 105-and 84-bp products of the 5Ј-and 3Ј-regions of the Phex gene, respectively, whereas those from Hyp mice only expressed a RT-PCR product of 105 bp (Fig. 8) . Immunocytochemical results showed that Phex protein was expressed only in wild-type osteoblast-like cells, and predominantly on their cell membrane (Fig. 9A ), but not in cells from Hyp mice (Fig. 9B) . Western blotting confirmed the absence of Phex protein in Hyp cells (Fig. 10) . 
Protein and gene expression of bone matrix proteins in BMC cultures
To examine whether bone matrix protein expression ex vivo is consistent with that observed in vivo, BMC from wildtype and Hyp mice were cultured for 18 days and analyzed by immunocytochemical staining (Fig. 9) and Western blotting (Fig. 10) . The areas of calcified nodule formation and immunodetectable osteocalcin were smaller in Hyp mouse cultures relative to wild-type mouse cultures by double staining for calcium and osteocalcin (Fig. 9, I and J, respectively). Similar results were observed with calcified nodule formation and type I collagen staining in Hyp vs. wild-type cultures (Fig. 9, G compared with H) . Immunodetectable bone sialoprotein and vitronectin were decreased significantly in both staining intensity and distribution in Hyp   FIG. 3 . Quantitative data for reaction products of immunostained bone matrix proteins from wild-type and Hyp mouse primary spongiosa. A, Percent immunopositive area of bone matrix proteins relative to total tissue area in the primary spongiosa. B, Abundance (summary total gray) of immunopositive reaction product in the primary spongiosa. C, Percent immunopositive area of bone matrix proteins relative to trabecular area in primary spongiosa. Immunostaining for bone matrix proteins was carried out on sections of PLP-fixed, decalcified, and paraffin-embedded distal femurs from wild-type and Hyp mice. Resulting positive reaction products were quantified by image analysis, as described in Materials and Methods. ColI, Type I collagen; OCN, osteocalcin; BSP, bone sialoprotein; VN, vitronectin; BGN, biglycan; FBN, fibrillin-1. *, **, and ***, Statistically significant difference (P Ͻ 0.05, P Ͻ 0.01, and P Ͻ 0.001) in the Hyp mice relative to the wild-type mice.
FIG. 4.
Quantitative data for reaction products of immunostained bone matrix proteins from wild-type and Hyp mouse cortical bone. A, Percent immunopositive area of bone matrix protein relative to total cortical bone area. In contrast to the primary spongiosa, total area measured in cortical bone was equivalent to that in total bone. Consequently, only immunopositivity relative to total cortical bone is shown. B, Abundance (summary total gray) of immunopositive reaction product in cortical bone. Immunostaining for bone matrix proteins was carried out on sections of PLP-fixed, decalcified, and paraffin-embedded distal femurs from wild-type and Hyp mice. The resulting positive products were quantitated by image analysis as described in Materials and Methods. ColI, Type I collagen; OCN, osteocalcin; BSP, bone sialoprotein; VN, vitronectin; BGN, biglycan; FBN, fibrillin-1. ** and ***, Statistically significant difference (P Ͻ 0.01 and P Ͻ 0.001) in Hyp mice relative to wild-type mice.
mouse cultures (Fig. 9, D and F, respectively) compared with wild-type mouse cultures (Fig. 9, C and E, respectively) . In contrast, biglycan and fibrillin-1 were at similar abundance in Hyp mice compared with those in wild-type mice by immunocytochemistry (data not shown). Western blot analysis ( Fig. 10) indicated that osteocalcin, bone sialoprotein, and vitronectin were down-regulated in cells from Hyp mouse BMC cultures compared with wild-type mouse BMC cultures, whereas biglycan and fibrillin-1 were at similar abundance. Gene expression studies confirmed a significant D) and fibrillin-1 (E-H) on PLP-fixed, decalcified, and paraffin-embedded bone sections from wild-type (A, C, E, and G) and Hyp (B, D, F, and H) mice. Biglycan is localized to osteoid (asterisks), some osteocytes, osteoblasts (arrow), and subperiosteal cells (arrowhead) in wild-type mice (A and C). Fibrillin-1 is localized to some osteocytes, osteoblasts, and some regions of bone and cartilage matrix in wild-type mice (E and G). In Hyp mice, substantially greater staining is observed for biglycan and fibrillin-1 in bone and cartilage matrix and in osteocytes of Hyp mice (B, D, F, and H). Counterstaining was performed with methyl green. decrease in type I collagen, osteocalcin, bone sialoprotein, and vitronectin mRNA in the Hyp cells relative to wild-type cells, whereas no significant change in biglycan and fibrillin mRNA expression was observed (Fig. 8) .
Effect of Hyp and wild-type conditioned medium on osteogenic cell proliferation, differentiation, and mineralization of BMC cultures
To examine whether Hyp BMC cultures release possible humoral factors that might act to induce a Hyp phenotype, BMC from wild-type mice were cultured for 18 days with 10% conditioned medium harvested from Hyp mouse or wild-type BMC cultures. The cultures were then analyzed by sequential cytochemical staining for total colonies, ALP, collagen, and calcium and quantitated by image analysis. The results showed that total colony area was unchanged; however, areas of ALP-, collagen-, and calcium-positive colonies were decreased significantly in the cultures treated with conditioned medium from Hyp mouse BMC cultures compared with those in cultures treated with conditioned medium from wild-type mouse BMC cultures (Fig. 11A) . When the positive percentages of ALP-, collagen, and calciumpositive colonies relative to total colonies were calculated, all were lower in the cultures treated with conditioned medium from Hyp mouse BMC cultures than in those from wild-type mouse BMC cultures (Fig. 11B) . When the percentages of ALP-, collagen, and calcium-positive colonies in Hyp mice relative to wild-type mice were calculated, ALP-, collagen-, and calcium-positive colony areas were decreased by 21.9%, 19.5%, and 25.0%, respectively (Fig. 11C) . The inhibition was not as dramatic as that seen when Hyp mouse BMC cultures per se were analyzed (Fig. 7) . Those findings suggest that factors released by Hyp mouse BMC cultures may result in partially retarded osteogenic cell differentiation and mineralization in an autocrine or paracrine manner.
Discussion
Although previous studies have shown that PHEX/Phex mRNA is expressed predominantly in bone and teeth and that a 3Ј-PHEX/Phex deletion is present in Hyp mice, localization of Phex protein to a cellular compartment in intact bone has not been reported to date. In our studies Phex protein was localized to osteoblasts, but predominantly to osteocytes in intact mouse bone. In COS cells transfected with complementary DNA encoding PHEX, we previously reported the subcellular localization of PHEX to the plasma membrane (10) . In the present studies Phex protein was seen in the plasma membrane of intact bone cells in situ as well as in the plasma membrane of cells derived from mouse BMC cultures in vitro. To verify the genotype of the ex vivo bone marrow cells, we confirmed the 3Ј-deletion of the Phex gene in cells derived from the Hyp mouse BMC cultures and also demonstrated the absence of Phex protein both in intact Hyp mouse bone and in cells derived from Hyp mouse BMC cultures.
Mineralization was decreased, as expected, in both the primary spongiosa and cortical bone of Hyp mice in situ. Diminished mineralization of Hyp mouse osteogenic BMC cultures was also observed ex vivo relative to that in wildtype mouse osteogenic BMC cultures despite similar levels of ambient phosphate. The in vitro mineralization defect was accompanied by a decrease in ALP and type I collagen in the cultures. Decreased type I collagen was also observed in situ within trabecular bone, and gene expression of type I collagen was diminished in osteogenic BMC in vitro. Impaired mineralization in vitro has also been observed in cultured immortalized osteoblasts prepared from Hyp mice, although expression of type I collagen was normal in that system (16).
FIG. 7.
Osteogenic cell differentiation and mineralization defects in cultured BMC from Hyp mice. A, BMC from wild-type (WT) and Hyp mice were cultured for 18 days, and resulting colonies were stained with methylene blue for total colonies and cytochemically for ALP, collagen (Col), and calcium (Ca). The areas of total, ALP-positive, collagen-positive, and calcium-positive colonies were measured by image analysis as described in Materials and Methods. * and **, Statistically significant difference (P Ͻ 0.05 and P Ͻ 0.01) in the Hyp mice relative to the wild-type mice. B, The percentages of ALPpositive, collagen-positive, and calcium-positive colonies relative to total colonies were calculated for wild-type and Hyp mouse colonies. C, The percentages of total colony area, ALP-positive, collagen-positive, and calcium-positive colonies in Hyp mouse BMC cultures were each compared as a percentage of the same parameter in wild-type mouse BMC cultures.
Nevertheless, both in vitro models demonstrate the presence of an intrinsic mineralization defect in Hyp mouse osteoblastic cells. Indeed, an intrinsic osteoblast defect resulting in impaired mineralization had previously been proposed by in vivo experiments in which Hyp osteoblastic cells were transplanted into normal mice in vivo (7) .
Hypomineralized periosteocytic lesions were observed in the Hyp mouse bone in situ. Such perilacunar lesions have also been observed in the bone of children with Hyp and have healed incompletely after therapy with phosphate and 1,25-dihydroxyvitamin D 3 . Our demonstration that Phex protein is normally expressed in osteocytes, therefore, supports the thesis that these lesions are due to a defect in the Hyp osteocyte that lacks Phex protein and is consistent with the view that the mineralization defect in Hyp/Hyp is intrinsic to osteogenic cells that express Phex protein.
We next examined whether the elaboration of several bone matrix proteins was altered by osteogenic cells. Our studies show that in vivo in Hyp mouse bone, osteocalcin immunostaining was reduced in trabecular and cortical bone, and this is in keeping with the reduced level of osteocalcin previously found in bone powder of Hyp mice (24) . Reduced osteocalcin protein and gene expression were also observed in our bone marrow cultures of Hyp mice in vitro. These studies contrast with gene expression studies of osteocalcin in cultures of immortalized osteoblasts (16) or in calvareal bone (24) from Hyp mice in which osteocalcin mRNA levels were unaltered or elevated, respectively. Such distinctions could represent differences in the stage of maturity of the osteogenic cells analyzed, the source of osteogenic cells studied by different workers, or the use of immortalization techniques. Regardless of these issues, whether selective osteocalcin deficiency can contribute to deficient bone mineralization in vivo remains uncertain (25, 26) .
In vivo biglycan and fibrillin-1 immunostaining were increased in both trabecular and cortical bone. Biglycan, also know as proteoglycan-2, has been found in many connective tissues and in osteoid and osteocytic lacunae of bone as in our studies (27) . In vivo biglycan-deficient mice and biglycandeficient humans (in Turner's syndrome or monosomy X) display growth retardation and decreased bone mass. In vitro, biglycan at high concentrations can also inhibit the growth and proliferation of mineral crystals (28) . Fibrillin-1 is the principal component of the microfibrillar aggregates in the skeleton as well as in the eyes and vascular tissue (29) . Our results show that fibrillin-1 is normally localized in osteoblasts and in some osteocytes and displays a patchy distribution in bone matrix of wild-type mice. In view of the fact that fibrillin-1-deficient mice display excess calcification in blood vessels (30) , fibrillin-1 excess, as seen in the bone of Hyp mice, may contribute to the diminished mineralization observed in this entity. Despite the increase in biglycan and fibrillin-1 protein deposition observed in Hyp mouse bone in vivo, no alteration in the levels of mRNA encoding these proteins was observed in osteogenic cells of Hyp mouse BMC cultures. In view of the fact that Phex appears to exert endopeptidase activity (10), Phex deficiency in osteogenic cells may contribute to delayed elimination of biglycan and fibrillin-1 in vivo and consequently facilitate their accumulation in the matrix of Hyp bone.
Finally, bone sialoprotein and vitronectin immunostaining were both decreased in Hyp mouse bone in vivo, and levels of their proteins were also diminished in Hyp mouse BMC cultures in vitro. Bone sialoprotein is relative unique to mineralizing tissue (31, 32) and is expressed only by those cells forming a mineralized matrix (33) . Bone sialoprotein expression in cell culture is maximal during early matrix mineralization (33) and in solution studies acts as a hydroxyapatite nucleator (34) . It has therefore been suggested that bone sialoprotein is involved in bone mineralization (35) (36) (37) ; however, the present study is the first to implicate bone sialoprotein in a mineralization defect in vivo.
Vitronectin is a multifunctional extracellular matrix glycoprotein that contains an RGD sequence and is involved in cell adhesion, spreading, and migration by interaction with integrins (38) . Vitronectin-deficient mice appear to demonstrate normal development, so in its absence, vitronectin functions may be subserved by alternate constituents of the extracellular matrix. It is unclear, however, whether bone will develop normally when vitronectin deficiency is accompanied by a reduction or an excess of other bone matrix proteins.
Gene expressions of bone sialoprotein and vitronectin were diminished in the osteogenic Hyp mouse bone marrow cultures. These results point to a differentiation defect in these cells; whether this is due to a different marrow cell precursor population or alteration in the normal marrow cell population is at present unclear. However, this defect appears to accompany and presumably indirectly result from the mutation in the Phex gene.
In view of the fact that Nesbitt et al. (39) recently demonstrated that conditioned medium from Hyp osteoblasts displays phosphate transport inhibitory activity, presumably due to phosphatonin, we assessed the effect of conditioned . The resulting colonies were stained with methylene blue for total colonies and cytochemically for ALP, collagen (Col), and calcium (Ca). The areas of total, ALP-positive, collagen-positive, and calciumpositive colonies were measured by image analysis as described in Materials and Methods. B, The percentages of ALP-positive, collagenpositive, and calcium-positive colonies relative to total colonies were calculated for wild-type and Hyp mouse colonies. *, Statistically significant difference (P Ͻ 0.05) in the Hyp mice relative to the wild-type mice. C, The percentages of total colony area and ALP-positive, collagen-positive, and calcium-positive colonies in wild-type BMC cultures incubated with Hyp-conditioned medium were each compared as a percentage of the same parameter in the wild-type BMC cultures incubated with wild-type conditioned medium.
medium from Hyp BMC to reproduce Hyp defects in wildtype BMC. The results indicated that under the experimental conditions used, partial defects could indeed be induced. Consequently, at least same of the abnormalities in these cells may be due to the action of a secreted factor, possibly synonymous with phosphatonin, which is acting in an autocrine or paracrine manner. In summary, then, our studies have localized Phex protein to osteoblastic and especially osteocytic cells and suggest that the hypomineralized periosteocytic lesions in Hyp bone may be a local consequence of Phex deficiency in the osteocyte. A reduction in some bone matrix proteins, such as bone sialoprotein and vitronectin, can be observed both in Hyp bone in vivo and in Hyp BMC cultures in vitro, whereas elevations in other bone matrix proteins, such as biglycan and fibrillin-1, may be seen. This perturbation of the normal complement of bone matrix protein may contribute to the impaired mineralization observed in Hyp bone and could potentially account for the inhibitory effect on normal bone cell mineralization previously reported to be elicited by Hyp bone cells (7, 16) . Based on analyses of osteogenic cells in vitro, these alterations in bone matrix protein concentrations may result from diminished gene expression or from altered posttranslational handling of these proteins. These studies demonstrate that osteogenic cell disturbances may occur independently of ambient phosphate concentrations and may therefore be of equal importance for the generation of the Hyp phenotype as the much studied changes in renal function in this disorder.
